Share chart IO Biotech, Inc.
Extended chart
Simple chart
About IO Biotech, Inc.
IO Biotech, Inc., биофармацевтическая компания клинической стадии, разрабатывает иммуномодулирующие методы лечения рака на основе технологической платформы T-win. Ведущий кандидат компании, IO102-IO103, предназначенный для воздействия на иммуносупрессивные белки, такие как индоламин-2,3-дегидрогеназа (IDO) и лиганд запрограммированной смерти (PD-L1), который находится на стадии 2 клинических испытаний для лечения меланомы. , а также в фазе 1 клинических испытаний для лечения рака легких, головы и шеи, мочевого пузыря и меланомы. more details| IPO date | 2021-11-05 |
|---|---|
| ISIN | US4497781090 |
| Industry | Biotechnology |
| Sector | Health Care |
| Валюта | usd |
| Валюта отчета | usd |
| Сайт | https://www.iobiotech.com |
| Цена ао | 0.871 |
| Change price per day: | 0% (0.945) |
|---|---|
| Change price per week: | +12.96% (0.8366) |
| Change price per month: | +0.5319% (0.94) |
| Change price per 3 month: | -28.95% (1.33) |
| Change price per half year: | -30% (1.35) |
| Change price per year: | -48.64% (1.84) |
| Change price per 3 year: | -86.5% (7) |
| Change price per 5 year: | 0% (0.945) |
| Change price per 10 year: | 0% (0.945) |
| Change price per year to date: | +3.85% (0.91) |
|
|
Underestimation
|
Efficiency
|
|||||||||||||||||||||||||||||||||||||
Dividends
|
Debt
|
Growth impulse
|
|||||||||||||||||||||||||||||||||||||
| Institutions | Volume | Share, % |
|---|---|---|
| Vivo Capital, LLC | 6173439 | 9.37 |
| Novo Holdings A/S | 5747067 | 8.72 |
| Samsara BioCapital, LLC | 3640015 | 5.53 |
| PFM Health Sciences, LP | 2341107 | 3.55 |
| Morgan Stanley | 2281682 | 3.46 |
| Marshall Wace LLP | 2105262 | 3.2 |
| Armistice Capital, LLC | 1924000 | 2.92 |
| Bank of America Corporation | 1844185 | 2.8 |
| Stonepine Capital Management, LLC | 1666037 | 2.53 |
| Pivotal bioVenture Partners Investment Advisor, LLC | 864197 | 1.31 |
| Head | Job title | Payment | Year of birth |
|---|---|---|---|
| Dr. Mai-Britt Zocca Ph.D. | Founder, President, CEO, Principal Financial Officer & Director | 733.88k | 1968 (57 years) |
| Prof. Inge Marie Svane M.D., Ph.D. | Founder & Clinical Advisor | N/A | |
| Anders Ljungqvist | Founder | N/A | |
| Prof. Per Thor Straten | Founder | N/A | |
| Ms. Amy B. Sullivan M.B.A. | Chief Financial Officer | 391.24k | 1971 (54 years) |
| Prof. Mads Hald Andersen M.D., Ph.D. | Co-Founder & Scientific Advisor | N/A | |
| Mr. Devin Whittemore Smith | Secretary, General Counsel & Chief Compliance Officer | N/A | 1968 (57 years) |
| Mr. Daniel G. Mannix Ph.D. | Senior Vice President of Regulatory Affairs | N/A | |
| Mr. Eric Faulkner M.B.A. | Chief Technical Officer | N/A | |
| Dr. Qasim Iftikhar Ahmad M.D. | Chief Medical Officer | 1971 (54 years) |
Address: Denmark, Copenhagen, Ole Maaløes Vej 3 - open in Google maps, open in Yandex maps
Website: https://www.iobiotech.com
Website: https://www.iobiotech.com
